SGLT2 Inhibitor (Dapagliflozin)
Treatment used for 1 condition
Total Trials
14
Total Participants
15K
Avg Effectiveness
70%
Avg Safety Score
60%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.